ICU Medical (ICU Medical) Interest Expense : $-103 Mil (TTM As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is ICU Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ICU Medical's interest expense for the three months ended in Dec. 2023 was $ -27 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-103 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ICU Medical's Operating Income for the three months ended in Dec. 2023 was $ -5 Mil. ICU Medical's Interest Expense for the three months ended in Dec. 2023 was $ -27 Mil. ICU Medical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ICU Medical Interest Expense Historical Data

The historical data trend for ICU Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ICU Medical Interest Expense Chart

ICU Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.55

-1.75

-0.86

-70.81

-102.73

ICU Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-19.74	-24.27	-25.83	-25.92	-26.71

ICU Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-103 Mil.

ICU Medical (NAS:ICUI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ICU Medical's Interest Expense for the three months ended in Dec. 2023 was $-27 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $1,633 Mil.

ICU Medical's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

ICU Medical did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

ICU Medical (ICU Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICU Medical Inc (NAS:ICUI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

951 Calle Amanecer, San Clemente, CA, USA, 92673

Website

https://www.icumed.com

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.

Executives

Daniel Woolson	officer: VP, GM-Infusion Capital	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Christian B. Voigtlander	officer: Chief Operating Officer	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Vivek Jain	director, officer: Chairman and CEO	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Elisha W Finney	director	C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Virginia Ruth Sanzone	officer: VP, General Counsel	951 CALLE AMANECER, SAN CLEMENTE CA 92673
George A Lopez	director, officer: Chairman, other: Chairman	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
William Seeger	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Smiths Group International Holdings Ltd	10 percent owner	C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB
Group Plc Smiths	10 percent owner	765 FINCHKEY ROAD, LONDON X0 00000
Kolleen T Kennedy	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Robert S Swinney	director	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Laurie Hernandez	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Brian Michael Bonnell	officer: Chief Financial Officer	ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Scott E Lamb	officer: Controller	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Kevin J Mcgrody	other: Controller	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673